BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease

The adenosine nucleoside analog BCX4430 is a direct-acting antiviral drug under investigation for the treatment of serious and life-threatening infections from highly pathogenic viruses, such as the Ebola virus. Cellular kinases phosphorylate BCX4430 to a triphosphate that mimics ATP; viral RNA poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Raymond, Kotian, Pravin, Warren, Travis, Panchal, Rekha, Bavari, Sina, Julander, Justin, Dobo, Sylvia, Rose, Angela, El-Kattan, Yahya, Taubenheim, Brian, Babu, Yarlagadda, Sheridan, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937725/
https://www.ncbi.nlm.nih.gov/pubmed/27095300
http://dx.doi.org/10.1016/j.jiph.2016.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937725/
https://www.ncbi.nlm.nih.gov/pubmed/27095300
http://dx.doi.org/10.1016/j.jiph.2016.04.002

Ejemplares similares